December 2013—Illumina announced the launch of its TruGenome Undiagnosed Disease Test provided by the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory. This new service uses whole genome sequencing to assist physicians in identifying the underlying genetic cause of a rare or undiagnosed disease.
The Illumina Clinical Services Laboratory uses Illumina next-generation sequencing technology to provide a complete picture of the genome. Illumina’s team performs the analysis using Illumina’s VariantStudio software for rigorous variant classification. VariantStudio aggregates data from multiple sources into a single database that is updated as new discoveries are made, ensuring that analysis is based on current knowledge of clinically relevant gene variants.
Illumina, 858-202-4500